2020-08-10
治療骨質疏鬆症的新藥Romosozumab ( Evenity 益穩挺)於2020年7月取得台灣藥證，正式在台灣上市。台灣已經１０多年沒有骨質疏鬆症的新藥上市了，這個藥物的上市可望將骨質疏鬆治療推向新的時代。 Romosozumab ( Evenity 益穩挺)在2019年4月被美國食品藥物管理局FDA核准上市，目前已經在美國、日本、歐洲都上市使用。這個藥物可以同時抑制流失以及促進新骨生長，提供「 […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.